Skip to main content
OpenTrials

Clinical trial condition

Gastroenteropancreatic NEC (GEP NEC)

Explore clinical trials studying Gastroenteropancreatic NEC (GEP NEC). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Gastroenteropancreatic NEC (GEP NEC) trial results

Recruiting

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

NCT07278479

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • United Theranostics Glen Burnie, Maryland, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • United Theranostics Princeton, New Jersey, United States
View Trial Details
Not Yet Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

NCT07488923

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • NYU Langone Health New York, United States
  • Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details

Related conditions